1
EXHIBIT 11
- 26 -
2
CROSS MEDICAL PRODUCTS, INC. AND SUBSIDIARIES
EXHIBIT 11
COMPUTATION OF NET INCOME PER SHARE
Years ended December 31,
------------------------
1996 1995 1994
---- ---- ----
Weighted average number of common shares
outstanding 4,772,082 4,661,332 4,475,954
Shares issuable pursuant to stock option plans
and stock warrants 232,812 (1) 219,464
----------- --------------- ----------
Weighted average shares outstanding, including
common stock equivalents 5,004,894 4,661,332 4,695,418
========= =========== ===========
Net income (loss) from continuing operations $ 50,000 $(1,442,000) $(1,176,000)
========= =========== ===========
Net income from discontinued operations $1,231,000 $ 1,083,000 $ 1,257,000
========= =========== ===========
Net income (loss) $1,281,000 $ (359,000) $ 81,000
========= =========== =============
Net income (loss) per share from continuing operations $ .01 $ (.31) $ (.25)
============= =============== ===============
Net income per share from discontinued
operations $ .25 $ .23 $ .27
============== =============== ================
Net income (loss) per share $ .26 $ (.08) $ .02
============== ============== ================
<FN>
Note: The application of the higher of quarter end or year end market prices
in calculating fully diluted earnings per share does not result in a
change to the calculation of primary earnings per share.
(1) Shares issuable under these common stock equivalents are anti-dilutive and
therefore have been excluded from this schedule.